A CDMO on the Covid-19 frontline

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Michael Quirmbach, Group Chief Executive Officer and President at Corden Pharma. Michael has been in the contract services space for 20 years. He joined Corden Pharma in 2014, holding positions as Vice President, Marketing and Sales and Chief Business Officer before becoming CEO & President in 2019. Prior to joining Corden Pharma, he held positions of increasing responsibility at AMRI, Solvias, Dr. Reddy’s and Siegfried AG.

Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with guest Michael Quirmbach, covering manufacturing and supplying front-line drug products in the fight against Covid-19. Michael explains what is has been like transitioning a big pharma cost/profit centre mindset culture to a more agile, customer-centric, resilient, CDMO service mentality. And finally they discuss the role of continuous education, openness to cultures, goal setting and daily routines in achieving incredible career success.

Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also love a positive rating! Molecule to Market is sponsored and funded by ramarketing. An international content, design and digital agency that helps companies get noticed, raise profile and generate leads in life sciences.